SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-06-015865
Filing Date
2006-03-10
Accepted
2006-03-10 17:20:52
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-1528_410ka.htm 10-K/A 1941548
2 CONSENTS OF EXPERTS AND COUNSEL a06-1528_4ex23d1.htm EX-23.1 3189
3 302 CERTIFICATION a06-1528_4ex31d1.htm EX-31.1 10350
4 302 CERTIFICATION a06-1528_4ex31d2.htm EX-31.2 10911
5 906 CERTIFICATION a06-1528_4ex32.htm EX-32 9275
6 GRAPHIC g15284dai001.jpg GRAPHIC 38584
  Complete submission text file 0001104659-06-015865.txt   2030070
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 06680236
SIC: 2834 Pharmaceutical Preparations